Sammy Wilson

Sammy Wilson

Democratic Unionist Party — East Antrim

Speaking in the House of Commons on 17 November 2026

Debate

Medicines and Healthcare Products Regulatory Agency

Contribution

Thank you, Sir John. The failures of the MHRA have been well documented. The speeches today have focused on the failure of covid vaccinations, but the failures go back a long time. They involve issues such as pelvic mesh—I can remember seeing a constituent whose life was destroyed by the insertion of pelvic mesh—as well as sodium valproate, breast implants, metal hip replacements and puberty blockers. The APPG on pandemic response and recovery, of which I am a member, has been focusing on covid vaccinations. Despite those failures being known, with a report having been made on them six years ago, no lessons appear to have been learned. The problems have been highlighted already this morning. First, we must question the independence of the MHRA. Is it independent financially? Half of its income comes from the pharmaceutical companies. Is it even independent politically? I sometimes wonder why the early signs of problems with the covid vaccine were not highlighted earlier. Was it because the Government were afraid that highlighting them may have made people wary of taking the vaccine? That is not a good reason. Some European countries had already identified problems with the AstraZeneca vaccine, yet it took six months for the MHRA to accept that there were problems with clotting and so on. The yellow card reporting mechanism has not worked. Only about 10% of serious cases, and 2% of non-serious cases, are highlighted. It may be that the system is too complicated, that doctors or patients do not know about it, or that there is not enough time to do the research, but if a reporting mechanism leads to only 10% of serious cases being highlighted, there must be something wrong with it. On transparency, the APPG on pandemic response and recovery has had difficulties in trying to get information. Even when we have asked pointed questions—not vague questions, but questions that there should have been answers to—there has been either no response or a delayed response. Another issue is the composition of the MHRA: patients are not represented properly on it. What kinds of reforms are required? First, there must be genuinely independent oversight. We cannot have a regulator that almost marks its own homework. Secondly, there should be mandatory reporting. When problems are highlighted, there should be a mechanism whereby doctors have to respond. If a patient comes in and highlights that they have taken a certain drug or vaccine and are having problems, there should be a mandatory reporting requirement.

More from Sammy Wilson

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Sammy Wilson's full parliamentary record including voting history, expenses and all other contributions, see the Sammy Wilson report card.